Landmark day as both leading indexes break 1000
Ha'aretz - Tel Aviv,Israel
But Tysabri poses a threat in the medium term, of
Tysabri's 5000 users in the US had shifted from
Copaxone. ...
See all stories on this topic

Even Safety Needs Limits
Barron's (subscription) - USA
In February 2005, the agency pressured biotechnology
companies Biogen and Elan to suspend sales of the
multiple-sclerosis drug Tysabri after two patients ...